VioKey Promedbioscience Tech Invest OÜ

Active Registry code 14358656 OÜ Tallinn Registered 24 Oct 2017
Compare

VioKey Promedbioscience Tech Invest OÜ is a OÜ based in Tallinn, registry code 14358656, status: active. Main activity: Research and experimental development on natural sciences and engineering. Its annual report for 2025 shows revenue of €0 and 0 employees.

Turnover
—
State taxes
48 €
Labour taxes
0 €
Employees
—

Q4 2025 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q3 2024 – Q4 2025
State taxes, € Q4 2025: 48 € · +2 300.0% vs Q1 2025
01020304050Q3 2024 Company: 50 €Q3·24Q1 2025 Company: 2 €Q1·25Q4 2025 Company: 48 €Q4·2501020304050Q3 2024 Company: 50 €Q3·24Q1 2025 Company: 2 €Q4 2025 Company: 48 €Q4·25
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q4 2025 — 48 — —
Q1 2025 — 2 — —
Q3 2024 — 50 — —

Financials by year

2018 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
0501001502018 Company: — Industry median: —20182019 Company: — Industry median: 0 €20192020 Company: 0 € Industry median: 150 €20202021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250501001502018 Company: — Industry median: —2019 Company: — Industry median: 0 €20192020 Company: 0 € Industry median: 150 €2021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -37 535 € · −734.1% vs 2024 · industry median 0 € · above 2% of the industry
-100 000-50 000050 000100 0002018 Company: — Industry median: —20182019 Company: 62 623 € Industry median: 3 €20192020 Company: -63 665 € Industry median: 28 €20202021 Company: 11 513 € Industry median: 1 €20212022 Company: 11 513 € Industry median: 0 €20222023 Company: 6 604 € Industry median: 0 €20232024 Company: -4 500 € Industry median: 0 €20242025 Company: -37 535 € Industry median: 0 €2025-100 000-50 000050 000100 0002018 Company: — Industry median: —2019 Company: 62 623 € Industry median: 3 €20192020 Company: -63 665 € Industry median: 28 €2021 Company: 11 513 € Industry median: 1 €20212022 Company: 11 513 € Industry median: 0 €2023 Company: 6 604 € Industry median: 0 €20232024 Company: -4 500 € Industry median: 0 €2025 Company: -37 535 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 2 362 464 € · −1.6% vs 2024
01 0002 0003 0002018 Company: —20182019 Company: 1 518 252 €20192020 Company: 1 850 954 €20202021 Company: 2 229 441 €20212022 Company: 2 399 163 €20222023 Company: 2 654 981 €20232024 Company: 2 399 999 €20242025 Company: 2 362 464 €202501 0002 0003 0002018 Company: —2019 Company: 1 518 252 €20192020 Company: 1 850 954 €2021 Company: 2 229 441 €20212022 Company: 2 399 163 €2023 Company: 2 654 981 €20232024 Company: 2 399 999 €2025 Company: 2 362 464 €2025
Equity, € thousand 2025: 40 439 € · −48.1% vs 2024
0501001502018 Company: —20182019 Company: 127 772 €20192020 Company: 64 107 €20202021 Company: 75 870 €20212022 Company: 75 870 €20222023 Company: 82 474 €20232024 Company: 77 974 €20242025 Company: 40 439 €20250501001502018 Company: —2019 Company: 127 772 €20192020 Company: 64 107 €2021 Company: 75 870 €20212022 Company: 75 870 €2023 Company: 82 474 €20232024 Company: 77 974 €2025 Company: 40 439 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 -37 535 0 2 362 464 40 439 0
2024 0 -4 500 0 2 399 999 77 974 0
2023 0 6 604 0 2 654 981 82 474 0
2022 0 11 513 0 2 399 163 75 870 0
2021 0 11 513 0 2 229 441 75 870 0
2020 0 -63 665 0 1 850 954 64 107 0
2019 — 62 623 0 1 518 252 127 772 0
2018 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
-92.8 %
Net profit / equity
Return on assets (ROA)
-1.6 %
Net profit / assets
Equity ratio
1.7 %
Equity / assets
Debt ratio
98.3 %
Liabilities / assets
Current ratio
2.10
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 11 Apr 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 9 Feb 2026 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 9 Sep 2025 Company’s own · audited e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 12 Feb 2024 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 29 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 17 Mar 2022 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 3 Mar 2021 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main

Rulings 13

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50068251 / M4
16 Oct 2024
 Fine for not filing the report 13 Nov 2024 In force
23 Nov 2024
 PDF
Ä 50068251 / M3
13 Jul 2024
 Warning of a fine: annual report not filed 12 Aug 2024 In force
13 Jul 2024
 PDF
Ä 50068251 / 9
24 Apr 2024
 Amendment under Code of Civil Procedure § 595¹ (1) In force
24 Apr 2024
 PDF
Ä 50068251 / 8
17 Apr 2024
 Amendment under Code of Civil Procedure § 595¹ (1) In force
17 Apr 2024
 PDF
Ä 50068251 / M2
29 Jan 2024
 Fine for not filing the report 29 Feb 2024 Deficiencies eliminated
2 Mar 2024
 PDF
Ä 50068251 / M1
7 Dec 2023
 Warning of a fine: annual report not filed 6 Jan 2024 Deficiencies eliminated
2 Mar 2024
 PDF
Ä 50068251 / 7
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50068251 / 6
3 May 2023
 Amendment entry In force
3 May 2023
 PDF
Ä 50068251 / 5
4 Jul 2019
 Amendment entry In force
4 Jul 2019
 PDF
Ä 50068251 / 4
14 Jun 2018
 Amendment entry In force
14 Jun 2018
 PDF
Ä 50068251 / 3
22 Jan 2018
 Amendment entry In force
22 Jan 2018
 PDF
Ä 50068251 / 2
20 Jan 2018
 Amendment entry In force
20 Jan 2018
 PDF
Ä 50068251
24 Oct 2017
 First entry In force
24 Oct 2017
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data